1-20 of 29
Norma Peter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incidence, Risk Factors, Treatment and Long Term Outcome of Refractory and First Relapse AML Patients in the OSHO Studies

Dietger Niederwieser, MD, Rainer Krahl, PhD, Christoph Kahl, MD, Hans-Heinrich Wolf, MD, Sebastian Scholl, Michael Cross, PhD, Ute Hegenbart, MD, Norma Peter, MD, Christian Niederwieser, MD, Axel Florschütz, Kolija Reifenrath, Niklas Zojer, Christian Jakob, MD, Christian Junghanss, MD, Herbert G. Sayer, MD PhD, Volker Schmidt, Sebastian Schwind, MD, Georg Maschmeyer, MD, Thomas Fischer, MD, Andreas Hochhaus, MD, Haifa Kathrin Al-Ali, MD, Thomas Heinicke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1358.
https://doi.org/10.1182/blood-2019-125262
Published: 2019
Journal Articles

A Predictive Score for Early Mortality during Induction Therapy in Newly Diagnosed Transplant-Eligible Multiple Myeloma - an Analysis from Five GMMG and HOVON Multicenter Phase III Trials

Elias K Mai, MD, Thomas Hielscher, PhD, Uta Bertsch, MD, Jana Schlenzka, MD, Hans Jürgen Salwender, Henk M Lokhorst, Markus Munder, MD, Bronno van der Holt, Christian Gerecke, MD, Michael Pfreundschuh, MD, Ulrich Duhrsen, Peter Brossart, MD, Sonja Zweegman, MD PhD, Kai Neben, Jens Hillengass, MD, Marc-Steffen S Raab, Dirk Hose, MD, Edo Vellenga, MD, Maximilian Merz, MD, Iris Breitkreutz, MD, Anna Jauch, Marie José Kersten, MD, Hans Martin, Hans-Walter Lindemann, Norma Peter, MD, Sandra Croockewit, MD, Igor Wolfgang Blau, MD, Christof Scheid, MD, Katja C. Weisel, Pieter Sonneveld, MDPhD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2016.
https://doi.org/10.1182/blood.V130.Suppl_1.2016.2016
Published: 2017
Journal Articles

Circulating Tumor Cells As a Surrogate Marker for Bone Marrow Minimal Residual Disease and an Adverse Prognostic Factor for Patients with Multiple Myelom

Stefanie Huhn, PhD, Mathias Hänel, MD, Thomas Hielscher, PhD, Uta Bertsch, MD, Hans Jürgen Salwender, Norma Peter, MD, Hartmut Kirchner, Helga Bernhard, MD, Martin Vogel, Ralf Angermund, Martin Goerner, MD, Katja C. Weisel, Jan Duering, Igor W Blau, Niels Weinhold, PhD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4359.
https://doi.org/10.1182/blood.V130.Suppl_1.4359.4359
Published: 2017
Journal Articles

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Dietger Niederwieser, MD, Verena Sophia Hoffmann, Dr., Markus Pfirrmann, PhD, Haifa Kathrin Al-Ali, MD, Sebastian Schwind, MD, Vladan Vucinic, MD, Rainer Krahl, PhD, Christoph Kahl, Hans-Heinrich Wolf, MD, Ute Kreibich, Prof., Detlef Hähling, Ute Hegenbart, MD, Carsten Hirt, Norma Peter, MD, Axel Florschuetz, Kolja Reifenrath, Antje Schulze, Niklas Zojer, MD, Sebastian Scholl, Christian Junghanss, MD, Wolfram Pönisch, Simone Heyn, MD, Herbert G. Sayer, Andreas Hochhaus, MD, Thomas Heinicke, MD, Thomas Fischer, MD, Alwin Krämer, MD, Peter Dreger, MD, Georg Maschmeyer, MD, Utz Krug, Maria Christina Sauerland, MSc, Achim Heinecke, Rüdiger Hehlmann, MD, Eva Lengfelder, MD, Wolfgang Hiddemann, MD, Hubert Serve, MD, Carsten Müller-Tidow, Wolfgang E Berdel, MD, Thomas Büchner
Journal: Blood
Blood (2016) 128 (22): 1066.
https://doi.org/10.1182/blood.V128.22.1066.1066
Published: 2016
Journal Articles

Higher Incidence of Secondary AML and Adverse Molecular Markers, Together with Lower CR and Higher AML Related Death Rates in Elderly Compared to Younger Patients: Results from 2435 Patients Included in the Two German AML Intergroup Studies

Dietger Niederwieser, MD, Verena Sophia Hoffmann, Dr., Utz Krug, MD, Rainer Krahl, PhD, Christina Sauerland, Dipl.-Math, Karsten Spiekermann, MD, Stefan K. Bohlander, MD, Ute Hegenbart, MD, Wolfram Poenisch, MD, Vladan Vucinic, MD, Michael Cross, PhD, Nadja Jaekel, MD, Markus Pfirrmann, Antje Schulze, Alwin Kraemer, MD, Georg Maschmeyer, MD, Christian Junghanss, MD, Sebastian Scholl, Christian Jakob, MD, Thomas Heinicke, MD, Detlev Haehling, Norma Peter, MD, Ute Kreibich, Prof., Christoph Busemann, MD, Haifa Kathrin Al-Ali, MD, Ahmet H. Elmaagacli, MD PhD, B Opitz, Hans-Heinrich Wolf, MD, Wolfgang Hiddemann, MD, Wolfgang E Berdel, MD, Thomas Buechner
Journal: Blood
Blood (2015) 126 (23): 2517.
https://doi.org/10.1182/blood.V126.23.2517.2517
Published: 2015
Journal Articles

Impact of Severe Infections during Induction Therapy on Dosage, Response and Survival in Newly Diagnosed Multiple Myeloma - a Subgroup Analysis from the Randomized Phase III Trial GMMG-HD4

Elias Karl Mai, MD, Christina Kunz, PhD, Uta Bertsch, MD, Hans-Juergen Salwender, MD, Michael Pfreundschuh, MD, Ulrich Duehrsen, MD, Peter Brossart, MD, Norma Peter, MD, Kai Neben, MD, Thomas Hielscher, Jens Hillengass, MD, Hans Martin, MD, Hans Walter Lindemann, MD, Christof Scheid, MD PhD, Katja C. Weisel, Igor W. Blau, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2015) 126 (23): 3187.
https://doi.org/10.1182/blood.V126.23.3187.3187
Published: 2015
Journal Articles

Higher Leukemia Free Survival after Post-Induction Hematopoietic Cell Transplantation Compared to Consolidation Therapy in Patients >60 Years with Acute Myelogenous Leukemia (AML): Report from the AML 2004 East German Study Group (OSHO)

Dietger Niederwieser, MD, Haifa Kathrin Al-Ali, MD, Rainer Krahl, PhD, Christoph Kahl, MD, Hans-Heinrich Wolf, MD, Ute Kreibich, MD, Vladan Vucinic, MD, Detlev Haehling, MD, Ute Hegenbart, MD, Alwin Kraemer, Carsten Hirt, MD, Norma Peter, Bernhard Opitz, MD, Axel Florschütz, MD, Kolja Reifenrath, Antje Schulze, MD, Niklas Zojer, MD, Sebastian Scholl, MD, Christian Jakob, MD, Christian Junghanss, MD, Wolfram Pönisch, MD, Simone Heyn, MD, Herbert G. Sayer, MD PhD, Andreas Hochhaus, MD, Thomas Heinicke, MD, Thomas Fischer, MD, Georg Maschmeyer, MD, Peter Dreger, MD
Journal: Blood
Blood (2014) 124 (21): 280.
https://doi.org/10.1182/blood.V124.21.280.280
Published: 2014
Journal Articles

Long Term Follow up of the AML97-Study for Patients with AML Older Than 60 Years: A Study of the East German Hematology and Oncology Study Group (OSHO)

Christoph Kahl, MD, Rainer Krahl, PhD, Haifa Kathrin Al-Ali, MD, Herbert G. Sayer, MD PhD, Antje Schulze, MD, Michael Herold, MDPhD, Mathias Hänel, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Lutz Uharek, MD, Georg Maschmeyer, MD, Detlev Hähling, MD, Christian Junghanss, MD, Norma Peter, Dietrich Kämpfe, MD, Erika Kettner, MD, Thomas Heinicke, MD, Thomas Fischer, MD, Ute Kreibich, MD, Hans-Heinrich Wolf, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2014) 124 (21): 3664.
https://doi.org/10.1182/blood.V124.21.3664.3664
Published: 2014
Journal Articles

Prognostic Factors for Overall Survival in Relapsed Acute Myeloid Leukemia

Thomas Heinicke, MD, Rainer Krahl, PhD, Christoph Kahl, MD, Sebastian Scholl, MD, Hans-Heinrich Wolf, MD, Detlev Hähling, MD, Ute Hegenbart, MD, Norma Peter, MD, Antje Schulze, MD, Axel Florschütz, MD, Kolja Reifenrath, Niklas Zojer, MD, Christian Jakob, MD, Christian Junghanss, MD, Herbert G. Sayer, MD PhD, Georg Maschmeyer, MD, Andreas Hochhaus, MD, Thomas Fischer, MD, Dietger Niederwieser, MD, Haifa Kathrin Al-Ali, MD
Journal: Blood
Blood (2014) 124 (21): 3666.
https://doi.org/10.1182/blood.V124.21.3666.3666
Published: 2014
Journal Articles

The Addition of Rituximab to CHOP Improves Failure-Free and Overall Survival of Mantle-Cell Lymphoma Patients – a Pooled Trials Analysis of the German Low-Grade Lymphoma Study Group (GLSG)

Eva Hoster, PhD, Michael Unterhalt, MD, Michael Pfreundschuh, Michael Hallek, MD, Roswitha Forstpointner, Bernd Metzner, Hermann Einsele, Jürgen Krauter, MD, Ulrich Dührsen, Wolf-Dieter Ludwig, Josef Birkmann, Norma Peter, Wolfram Klapper, MD, Martin H. Dreyling, Wolfgang Hiddemann, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1752.
https://doi.org/10.1182/blood.V124.21.1752.1752
Published: 2014
Journal Articles

Increasing The Dose Of AraC In Consolidation Therapy Does Not Lead To Higher Overall Survival Or Improved Relapse Incidence In Patients With AML Over The Age Of 60 Years

Dietger Niederwieser, MD, Rainer Krahl, PhD, Christian Jakob, MD, Thomas Heinicke, MD, Christoph Kahl, MD, Antje Schulze, MD, Hans-Heinrich Wolf, MD, Bernhard Opitz, MD, Ute Kreibich, MD, Frank Rothmann, MD, Christian Junghanss, MD, Detlev Haehling, MD, Manfred Schulze, MD, Norma Peter, MD, Ute Hegenbart, MD, Haifa Kathrin Al-Ali, MD, Carsten Hirt, MD, Wolfram Poenisch, MD, Thoralf Lange, Simone Heyn, Vladan Vucinic, Kristina Bartsch, Thomas Fischer, M.D. Ph.D., Georg Maschmeyer, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2013) 122 (21): 2645.
https://doi.org/10.1182/blood.V122.21.2645.2645
Published: 2013
Journal Articles

Prognostic Factors For Overall Survival In Elderly Patients With Relapsed Acute Myeloid Leukemia – Retrospective Study On Behalf Of The East German Study Group For Hematology and Oncology (OSHO)

Thomas Heinicke, MD, Rainer Krahl, PhD, Christian Jakob, MD, Christoph Kahl, MD, Hans-Heinrich Wolf, MD, Ute Kreibich, MD, Frank Rothmann, MD, Detlev Hähling, MD, Manfred Schulze, MD, Ulrich Wedding, MD, Ute Hegenbart, MD, Carsten Hirt, MD, Norma Peter, MD, Hans-Heinrich Wolf, MD, Bernhard Opitz, MD, Antje Schulze, MD, Christian Junghanss, MD, Andreas Hochhaus, MD, Thomas Fischer, MD, Dietger Niederwieser, MD, Haifa Kathrin Al-Ali, MD
Journal: Blood
Blood (2013) 122 (21): 1409.
https://doi.org/10.1182/blood.V122.21.1409.1409
Published: 2013
Journal Articles

The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL

Clinical Trials & Observations
Carsten Müller, Niels Murawski, Martin H. J. Wiesen, Gerhard Held, Viola Poeschel, Samira Zeynalova, Michael Wenger, Christina Nickenig, Norma Peter, Eva Lengfelder, Bernd Metzner, Tanja Rixecker, Carsten Zwick, Michael Pfreundschuh, Marcel Reiser
Journal: Blood
Blood (2012) 119 (14): 3276–3284.
https://doi.org/10.1182/blood-2011-09-380949
Published: 2012
Journal Articles

Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

Clinical Trials & Observations
Kai Neben, Henk M. Lokhorst, Anna Jauch, Uta Bertsch, Thomas Hielscher, Bronno van der Holt, Hans Salwender, Igor W. Blau, Katja Weisel, Michael Pfreundschuh, Christof Scheid, Ulrich Dührsen, Walter Lindemann, Ingo G. H. Schmidt-Wolf, Norma Peter, Christian Teschendorf, Hans Martin, Mathias Haenel, Hans G. Derigs, Marc S. Raab, Anthony D. Ho, Helgi van de Velde, Dirk Hose, Pieter Sonneveld, Hartmut Goldschmidt
Journal: Blood
Blood (2012) 119 (4): 940–948.
https://doi.org/10.1182/blood-2011-09-379164
Published: 2012
Includes: Supplemental data
Journal Articles

Combining Information Regarding Chromosomal Aberrations t(4;14), Del(17p13) and the Copy Number of 1q21 with the International Staging System Classification Allows Stratification of Myeloma Patients Undergoing Autologous Stem Cell Transplantation: Results From the HOVON-65/GMMG HD4 Trial

Kai Neben, MD, Henk M. Lokhorst, MD, Anna Jauch, PhD, Uta Bertsch, MD, Thomas Hielscher, Christiane Heiss, Bronno van der Holt, PhD, Stefan Schmitt, Laila el Jarari, MSc, Hans J. Salwender, MD, Igor W. Blau, Michael Pfreundschuh, MD, Katja Weisel, MD, Ulrich Duehrsen, MD, Walter Lindemann, Christian Teschendorf, Hans Martin, Christof Scheid, Mathias Haenel, MD, Hans Guenter Derigs, Ullrich Graeven, Ingo GH Schmidt-Wolf, Norma Peter, Mohammed Wattad, MD, Steffen P Luntz, Annemiek Broyl, MD, Joerg Schubert, MD, Martin Hoffmann, Martin Goerner, MD, Jochen Tischler, Martin Kaufmann, MD, Marc S Raab, Anthony D. Ho, MD, Helgi van de Velde, MD, PhD, Dirk Hose, MD, Pieter Sonneveld, MD, PhD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2011) 118 (21): 332.
https://doi.org/10.1182/blood.V118.21.332.332
Published: 2011
Journal Articles

Long Term Outcome After Low Dose TBI Based Conditioning Hematopoietic Stem Cell Transplantation (HSCT) From Related and Unrelated Donors for Older Patients with AML

Dietger Niederwieser, MD, Leo F Verdonck, Jan J Cornelissen, MD PhD, Michael Cross, PhD, Rainer Krahl, MD, Thoralf Lange, Vladan Vucinic, Georg Franke, MD, Haifa K. Al-Ali, MD, Gert Ossenkoppele, MD, PhD, Georg Maschmeyer, MD, Gottfried Doelken, MD, Mathias Freund, MD, Norma Peter, Marc Boogaerts, MD, PhD, Alois Gratwohl, MD, Harry C. Schouten, MD, PhD, Bob Lowenberg, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2030.
https://doi.org/10.1182/blood.V118.21.2030.2030
Published: 2011
Journal Articles

Bortezomib-Based Induction Therapy Followed by Autologous Stem Cell Transplantation and Maintenance Therapy with Bortezomib Improves Outcome In Myeloma Patients with Gain 1q21 and t(4;14) - a Subgroup Analysis of the HOVON-65/GMMG-HD4 Trial

Hartmut Goldschmidt, Kai Neben, Uta Bertsch, Thomas Hielscher, Bronno van der Holt, Dirk Hose, Laila el Jarari, Hans Salwender, Igor Wolfgang Blau, Michael Pfreundschuh, Ulrich Duehrsen, Katja Weisel, Hans Martin, Walter Lindemann, Christian Teschendorf, Mathias Haenel, Christof Scheid, Helgi van de Velde, Hans Guenter Derigs, Martin Hoffmann, Norma Peter, Martin Kaufmann, Ingo Schmidt-Wolf, Anna Jauch, Henk M Lokhorst, Pieter Sonneveld
Journal: Blood
Blood (2010) 116 (21): 305.
https://doi.org/10.1182/blood.V116.21.305.305
Published: 2010
Journal Articles

Influence of Renal Function on Outcome of VAD or Bortezomib, Doxorubicin, Dexamethasone (PAD) Induction Treatment Followed by High-Dose Melphalan (HDM): A Subgroup Analysis From the HOVON-65/GMMG-HD4 Randomized Phase III Trial for Newly Diagnosed Multiple Myeloma

Christof Scheid, Pieter Sonneveld, Ingo Schmidt-Wolf, Bronno van der Holt, Thomas Hielscher, Laila el Jarari, Uta Bertsch, Hans Salwender, Sonja Zweegman, Mathias Hänel, Edo Vellenga, Joerg Schubert, Igor Wolfgang Blau, Asiong Jie, Helgi Van de elde, Norma Peter, Martijn Schaafsma, Walter Lindemann, Marie Jose Kersten, Ulrich Duehrsen, Michel Delforge, Katja Weisel, Sandra Croockewit, Hans Martin, Shulamit Wittebol, Harry Schouten, Marinus van Marwijk-Kooy, Pierre Wijermans, Henk M Lokhorst, Hartmut Goldschmidt
Journal: Blood
Blood (2010) 116 (21): 2396.
https://doi.org/10.1182/blood.V116.21.2396.2396
Published: 2010
Journal Articles

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

Clinical Trials & Observations
Norbert Schmitz, Lorenz Trümper, Marita Ziepert, Maike Nickelsen, Anthony D. Ho, Bernd Metzner, Norma Peter, Markus Loeffler, Andreas Rosenwald, Michael Pfreundschuh
Journal: Blood
Blood (2010) 116 (18): 3418–3425.
https://doi.org/10.1182/blood-2010-02-270785
Published: 2010
Includes: Supplemental data
Journal Articles

Mito-FLAG with Ara-C as Bolus Vs. Continuous Infusion in Recurrent AML – Results of a Prospective Randomized Intergroup Study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemias (SAL)

Mathias Hanel, Kai Friedrichsen, Frank Kroschinsky, Wolfram Poenisch, Kerstin Schaefer-Eckart, Walter Aulitzky, Norma Peter, Sascha Neugebauer, Regina Herbst, Annette Hanel, Martin Wilhelm, Dietger Niederwieser, Gerhard Ehninger, Friedrich Fiedler
Journal: Blood
Blood (2008) 112 (11): 2972.
https://doi.org/10.1182/blood.V112.11.2972.2972
Published: 2008